Oct 27, 2021 08:00AM
Aug 5, 2021 08:00AM
Jun 8, 2021 11:18AM
Feb 17, 2021 10:04AM
Jun 9, 2020 04:04PM
Jun 9, 2020 04:02PM
Oct 24, 2019 04:48PM Melinta Therapeutics (MLNT) Reports FDA Approval of Supplemental NDA for BAXDELA (delafloxacin) for Treatment of CABP
Oct 24, 2019 04:02PM
Oct 24, 2019 04:02PM
Aug 9, 2019 07:40AM
Aug 9, 2019 07:30AM
Aug 9, 2019 07:30AM
Jul 16, 2019 07:32AM
Jul 16, 2019 07:30AM Melinta Therapeutics Announces Preliminary Second Quarter 2019 Financial Results and Provides Corporate Update
Jul 16, 2019 07:30AM
Jun 19, 2019 07:31AM
Jun 19, 2019 07:30AM
Jun 19, 2019 07:30AM
May 9, 2019 04:00PM
May 9, 2019 04:00PM
Apr 8, 2019 07:30AM Melinta Therapeutics Announces Multiple Presentations at the 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
Apr 8, 2019 07:30AM
Mar 14, 2019 09:30AM
Mar 13, 2019 04:00PM
Mar 13, 2019 04:00PM
Nov 27, 2018 08:07AM
Nov 27, 2018 08:00AM
Nov 7, 2018 07:00AM Melinta Therapeutics Reports Third Quarter 2018 Financial Results
Nov 7, 2018 07:00AM
Oct 29, 2018 08:07AM
Oct 29, 2018 08:00AM
Oct 2, 2018 08:05AM
Oct 2, 2018 08:00AM
Sep 21, 2018 07:37AM
Sep 21, 2018 07:37AM Melinta Therapeutics Receives Positive CHMP Opinion for Vabomere™ (meropenem and vaborbactam)
Sep 11, 2018 09:26AM
Aug 3, 2018 01:37PM
Aug 3, 2018 01:31PM
May 31, 2018 08:00AM
May 24, 2018 09:23AM
Apr 23, 2018 08:06AM
Apr 23, 2018 08:00AM Melinta Therapeutics Presents Results from VABOMERE TANGO II Trial at ECCMID 2018, Highlighting Outcomes in Vulnerable Patient Populations
Apr 16, 2018 08:00AM
Mar 13, 2018 07:00AM
Mar 8, 2018 07:00AM
Mar 2, 2018 07:00AM
Feb 28, 2018 07:00AM
Feb 27, 2018 04:44PM
Feb 27, 2018 04:05PM Melinta Therapeutics Publishes Complete Results from Phase 3 TANGO I Study of VABOMERE™ (meropenem and vaborbactam) in Patients with cUTI
Feb 20, 2018 07:00AM

322,899 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All